Literature DB >> 9844588

Tissue heterogeneity of immunohistochemically detected estrogen receptor. Implications for image analysis quantification.

L J Layfield1, E Saria, E E Mooney, K Liu, R R Dodge.   

Abstract

The increasingly popular immunohistochemical techniques for assay of the estrogen receptor (ER) allow localization of receptor positivity to specific cell populations. Heterogeneity of the ER in tumor cell populations may have important implications for analytic cell selection and for prognosis in ER-positive carcinomas. We studied 84 tissue blocks for level-to-level and geographic heterogeneity within level of the ER and cytokeratin by staining alternate serial sections for ER and cytokeratin. Distribution of ER and cytokeratin positivity was manually assessed. Homogenous positive staining was seen in 63 of 84 cases for ER and 71 of 84 cases for cytokeratin. Distinct geographic variability constant from level to level was seen in 7 cases for ER. In each of these cases, the cell populations stained uniformly for cytokeratin. Artifactual heterogeneity seemed to be uncommon for ER. Automated image analysis and manual ER estimation resulted in more positive cases than did the dextran-coated charcoal (DCC) technique. Interobserver correlation for the manual method seemed high, as did correlation between the manual method and image analysis. Because a majority of the immunohistochemical staining heterogeneity for ER seemed to be biologic, we believe it may mark carcinomas that are less responsive to tamoxifen and more likely to progress than would be predicted by more traditional methods of ER analysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844588     DOI: 10.1093/ajcp/110.6.758

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.

Authors:  Robyn Macfarlane; Melanie Seal; Caroline Speers; Ryan Woods; Hamad Masoudi; Samuel Aparicio; Stephen K Chia
Journal:  Oncologist       Date:  2012-01-20

2.  Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.

Authors:  Nidal M Almasri; Mohammad Al Hamad
Journal:  Breast Cancer Res       Date:  2005-05-24       Impact factor: 6.466

3.  Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer?

Authors:  W Al Sarakbi; M Salhab; V Thomas; K Mokbel
Journal:  Int Semin Surg Oncol       Date:  2005-08-22

4.  Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays.

Authors:  Gøril Knutsvik; Ingunn M Stefansson; Sura Aziz; Jarle Arnes; Johan Eide; Karin Collett; Lars A Akslen
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

5.  Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.

Authors:  Govindasamy-Muralidharan Karthik; Mattias Rantalainen; Gustav Stålhammar; John Lövrot; Ikram Ullah; Amjad Alkodsi; Ran Ma; Lena Wedlund; Johan Lindberg; Jan Frisell; Jonas Bergh; Johan Hartman
Journal:  BMC Cancer       Date:  2017-11-29       Impact factor: 4.430

6.  The Quantitative ER Immunohistochemical Analysis in Breast Cancer: Detecting the 3 + 0, 4 + 0, and 5 + 0 Allred Score Cases.

Authors:  Ivan R Ilić; Nikola M Stojanović; Niko S Radulović; Vesna V Živković; Pavle J Randjelović; Aleksandar S Petrović; Marina Božić; Ratko S Ilić
Journal:  Medicina (Kaunas)       Date:  2019-08-10       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.